Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether adult DKA patients who present to the emergency department treated with early subcutaneous long acting insulin versus standard care receive a shorter total duration of intravenous (IV) insulin infusion.


Clinical Trial Description

Specific Aims: To evaluate the impact of early administration of subcutaneous glargine versus standard care on time of insulin infusion in DKA patients and other secondary outcomes listed in this application. Methods: DKA patients enrolled in this study will receive the long acting glargine dose (0.3 units/kg with a maximum dose of 30 units) within two hours after initiation the IV insulin infusion. Besides timing of the glargine dose, no other changes in standard patient care will occur in those patients enrolled in this study, the same labs will be collected and the insulin infusion will be titrated using the same hospital protocol algorithm. Patients enrolled in the prospective arm will be compared with the retrospective control group, which received standard insulin therapy (subcutaneous insulin glargine administered at least 2 to 3 hours prior to termination of the insulin infusion). There will be 18 patients in this group selected in reverse chronological order from our pre-specified date range of 8/1/2014 to 7/31/2016. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02930044
Study type Interventional
Source University of Maryland, Baltimore
Contact
Status Completed
Phase N/A
Start date October 2016
Completion date November 1, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Completed NCT03660189 - Two Bag System for Diabetic Ketoacidosis N/A
Terminated NCT03066440 - Double Blinded Randomized Control Trial of Types of IVF in Children With DKA Phase 4
Completed NCT04940897 - Use of Blood Ketone Meters to Improve Ambulance Hyperglycaemia Care N/A
Completed NCT04926740 - Intravenous Fluids in Adults With Diabetic Ketoacidosis in the Emergency Department N/A
Terminated NCT04567225 - Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management Phase 4
Completed NCT04017221 - Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
Recruiting NCT03717896 - Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis Phase 2
Terminated NCT02548494 - Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes N/A
Completed NCT02006342 - Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis N/A
Completed NCT01753921 - Evaluation of a Non-invasive Brain Compliance Measurement Device
Completed NCT01365793 - Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis Phase 3
Completed NCT00426413 - Ketosis Prone Diabetes in African-Americans N/A
Not yet recruiting NCT05867797 - Risk Factors and Outcomes of Acute Kidney Injury in Patients With Diabetic Ketoacidosis at Sohag University Hospital.
Terminated NCT04234867 - Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D) Phase 1
Not yet recruiting NCT05752279 - Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis Phase 3
Completed NCT04825639 - Identifying Risk Factors for Developing AKI in Sepsis
Recruiting NCT05155917 - Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care Phase 2
Recruiting NCT05383404 - Clinical and Laboratory Parameters Associated With Different Degrees of Dehydration Among Children With Diabetic Ketoacidosis
Completed NCT00629707 - Cerebral Edema in Pediatric Diabetic Ketoacidosis N/A